A Word from PharmExec

April 1, 2020

A note from the editors regarding the magazine, webcasts and other activities.

Like everyone, the staff of Pharmaceutical Executive and our parent company MJH Life Sciences is pivoting to address the current needs of our readers and clients.

 

If you are one of our print subscribers, we realize that if you receive the monthly publication at your workplace, you might not receive it. So we will deliver the digital version/PDF to you via email, if we have your email. Please note that your issues will still be delivered to you via postal mail, and will be awaiting your return to the office. If you wish to change your delivery address, or delivery preference, you can do so via our online subscription form.

 

If you are a regular webcast viewer, please note they are still the most popular form of learning right now. Our sister brands at LCGC and Spectroscopy are addressing COVID-19 concerns in the lab. Please note, all of our webcasts are available OnDemand, so if you have missed any, you can go back and watch.

 

More webinars were launched this week to our healthcare audience, including “Managing Lung Cancer Patients Through the COVID-19 Pandemic: What to Know” on the MJH Life Sciences OncLive brand.

 

The MJH Life Sciences teams also converted two live full-day, multi-speaker CME-accredited meetings to digital formats within a 48 hour time frame, and we now have a virtual format for dinner events or summits, which is particularly important to the pharma companies used to working in-person. You can reach our business development team if you want to discuss.

 

And, as always, you can reach the editors directly at their emails with news, articles or questions.

 

Remember to visit us on LinkedIn, Twitter, Instagram or Soundcloud for our latest information, COVID or otherwise.